Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.

Le DT, Diaz LA Jr, Kim TW, Van Cutsem E, Geva R, Jäger D, Hara H, Burge M, O'Neil BH, Kavan P, Yoshino T, Guimbaud R, Taniguchi H, Élez E, Al-Batran SE, Boland PM, Cui Y, Leconte P, Marinello P, André T

Open source

DOI
10.1016/j.ejca.2023.02.016
Published
2023 Jun
Container
European journal of cancer (Oxford, England : 1990)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2023.02.016,
  title = {Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.},
  author = {Le DT and Diaz LA Jr and Kim TW and Van Cutsem E and Geva R and Jäger D and Hara H and Burge M and O'Neil BH and Kavan P and Yoshino T and Guimbaud R and Taniguchi H and Élez E and Al-Batran SE and Boland PM and Cui Y and Leconte P and Marinello P and André T},
  year = {2023},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2023.02.016},
  url = {https://doi.org/10.1016/j.ejca.2023.02.016}
}

RIS

TY  - JOUR
TI  - Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.
AU  - Le DT
AU  - Diaz LA Jr
AU  - Kim TW
AU  - Van Cutsem E
AU  - Geva R
AU  - Jäger D
AU  - Hara H
AU  - Burge M
AU  - O'Neil BH
AU  - Kavan P
AU  - Yoshino T
AU  - Guimbaud R
AU  - Taniguchi H
AU  - Élez E
AU  - Al-Batran SE
AU  - Boland PM
AU  - Cui Y
AU  - Leconte P
AU  - Marinello P
AU  - André T
PY  - 2023
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2023.02.016
UR  - https://doi.org/10.1016/j.ejca.2023.02.016
ER  - 

APA

DT, L., Jr, D. L., TW, K., E, V. C., R, G., D, J., H, H., M, B., BH, O., P, K., T, Y., R, G., H, T., E, É., SE, A., PM, B., Y, C., P, L., P, M., & T, A. (2023). Pembrolizumab for previously treated, microsatellite instability-high/mismatch repair-deficient advanced colorectal cancer: final analysis of KEYNOTE-164.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2023.02.016

Source records